中信建投证券股份有限公司 关于西安铂力特增材技术股份有限公司 2024年年度报告的信息披露监管问询函的核查意见 上海证券交易所： 西安铂力特增材技术股份有限公司（以下简称"铂力特"、"公司"）于 2025年5月15日收到贵所下发的《关于西安铂力特增材技术股份有限公司2024年 报告的信息披露监管问询函》（上证科创公函【2025】0120号，以下简称"问 询函"）。中信建投证券股份有限公司（以下简称"保荐人"、"中信建投"） 作为铂力特2022年度向特定对象发行A股股票并在科创板上市的保荐人，根据 《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》等相关法 律法规的规定和问询函的要求，对问询函中相关问题进行了审慎核查和落实， 现回复说明如下： 1.关于收入变动合理性。 年报显示，报告期公司实现营业收入13.23亿元，同比增长15.02%，销售模 式上，收入均来源于直销。客户所处领域方面，航空航天仍为公司营业收入的 主要来源。主要客户变动方面，新增第五大客户系公司海外客户的贸易商，该 海外客户采购公司自研3D打印设备增长较多。请公司 ...

证券代码：688333 证券简称：铂力特 公告编号：2025-028 西安铂力特增材技术股份有限公司 关于2024年报告的信息披露监管 问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 西安铂力特增材技术股份有限公司（以下简称"公司"）于近日收到上海 证券交易所（以下简称"上交所"）出具的《关于西安铂力特增材技术股份有 限公司2024年报告的信息披露监管问询函》（上证科创公函【2025】0120号）， 以下简称"问询函"），公司会同相关中介机构对问询函所列问题进行了认真 研究和逐项落实，现就有关问题回复如下： 本回复中若出现总计数尾数与所列数值总和尾数不符的情况，均为四舍五 入所致。如无特别说明，本回复中使用的简称或名词释义与《西安铂力特增材 技术股份有限公司2024年年度报告（修订版）》一致。 基于商业秘密和商业敏感信息，根据相关法律法规、规范性文件及公司《 信息披露暂缓与豁免事务管理制度》，公司已履行相应信息豁免披露程序，对 本次问询函回复中关于客户和供应商名称等事项进行豁免披露处理。 1.关于收入变动 ...

Meeting Overview - The shareholders' meeting of Xi'an Plater Technology Co., Ltd. was held on June 9, 2025, at the company's conference room in Xi'an, Shaanxi Province [1] - A total of 118 ordinary shareholders attended the meeting, holding 118,738,529 voting rights, which accounted for 44.0627% of the company's total voting rights [1] Voting Results - All non-cumulative voting proposals were approved during the meeting [1] - The voting results showed that 118,727,349 ordinary shares (99.9905%) voted in favor, with 7,190 shares (0.0060%) against, and 3,990 shares (0.0035%) abstaining [2] - Another proposal received 118,729,349 votes in favor (99.9922%), with 5,190 against (0.0043%) and 3,990 abstaining (0.0035%) [2] - A further proposal had 118,728,015 votes in favor (99.9911%), with 6,524 against and 3,990 abstaining [2] Legal Compliance - The meeting was convened by the board of directors and chaired by the chairman and general manager, Mr. Xue Lei, following legal and procedural requirements [1] - The legal representatives confirmed that the meeting's convening, attendance, and voting procedures were all compliant with the Company Law and the company's articles of association [5]

Group 1 - The legal opinion letter is issued by Beijing Jincheng Tongda (Xi'an) Law Firm for Xi'an Bolite Additive Technology Co., Ltd. regarding the 2024 annual shareholders' meeting scheduled for June 9, 2025 [3][4] - The shareholders' meeting was convened by the company's third board of directors and the notice was published on May 20, 2025, in designated media [5][7] - A total of 118 shareholders attended the meeting, representing 118,738,529 shares, which is 44.0627% of the total voting shares [8] Group 2 - The meeting was held at the company's headquarters, and the actual time and location matched the announced details [7][9] - The voting process combined on-site and online voting, with results verified by the law firm [9][17] - The voting results showed that various resolutions were approved with significant support from shareholders, including 99.9431% approval from minority shareholders for certain resolutions [11][12][17] Group 3 - The legal opinion confirms that the meeting's procedures, participant qualifications, and voting processes complied with relevant laws and regulations [4][9][17] - The law firm conducted thorough verification of the meeting's documentation and confirmed the accuracy and completeness of the information provided by the company [4][18] - The legal opinion letter is effective upon signature and seal by the law firm's responsible parties [18]

西安铂力特增材技术股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 06 月 09 日 （二） 股东大会召开的地点：陕西省西安市高新区上林苑七路 1000 号西安铂力 特增材技术股份有限公司综合楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： 证券代码：688333 证券简称：铂力特 公告编号：2025-027 | 1、出席会议的股东和代理人人数 | 118 | | --- | --- | | 普通股股东人数 | 118 | | 2、出席会议的股东所持有的表决权数量 | 118,738,529 | | 普通股股东所持有表决权数量 | 118,738,529 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 44.0627 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的 ...

北京金诚同达（西安）律师事务所 2024 年年度股东大会 之 法律意见书 （2025）JTN(XA)意字第 FY0609127 号 陕西省西安市高新区锦业路 12 号迈科商业中心 25 层 710065 电话：029-8112 9966 传真：029-8112 1166 | 一、本次股东大会的召集与召开程序 - | 4 - | | --- | --- | | 二、本次股东大会召集人和出席本次股东大会人员的资格 - | 5 - | | 三、本次股东大会的表决程序及表决结果 - | 5 - | | 四、结论意见 - | 10 - | 关于 西安铂力特增材技术股份有限公司 北京金诚同达（西安）律师事务所关于 西安铂力特增材技术股份有限公司 2024 年年度股东大会 之 法律意见书 （2025）JTN(XA)意字第 FY0609127 号 致：西安铂力特增材技术股份有限公司 西安铂力特增材技术股份有限公司（以下简称"公司"）2024 年年度股东大会 （以下简称"本次股东大会"）于 2025 年 6 月 9 日下午 15:00 在陕西省西安市高 新区上林苑七路 1000 号西安铂力特增材技术股份有限公司综合楼会议室召开 ...

Investment Rating - The report maintains a strong buy recommendation for the company [2] Core Views - The company achieved a revenue of 1.326 billion yuan in 2024, representing a year-on-year growth of 15.02%, while the net profit attributable to shareholders decreased by 5.26% to 104 million yuan [6][9] - The company is expanding into new markets such as 3C electronics, humanoid robots, and commercial aerospace, which are expected to drive future growth [9] Financial Performance Summary - In 2024, the company reported a revenue of 1.326 billion yuan, with a year-on-year increase of 15.02%. The net profit attributable to shareholders was 104 million yuan, down 5.26% year-on-year. The non-recurring net profit was 35.67 million yuan, a decrease of 51.98% year-on-year [6][8] - For Q1 2025, the company generated a revenue of 227 million yuan, up 7.30% year-on-year, but reported a net loss of 14.95 million yuan, a significant decline of 1661.37% year-on-year [6][7] - The company’s gross margin for 2024 was 37.44%, down 9.77 percentage points year-on-year, and the net margin was 7.88%, down 1.69 percentage points year-on-year [6] Business Segment Performance - Revenue from 3D printing customized products and technical services reached 689 million yuan, up 23.51% year-on-year, with a gross margin of 33.16% [6] - The aerospace sector generated 815 million yuan in revenue, a year-on-year increase of 33.08%, while the industrial sector saw a slight decline in revenue [6] Regional Performance - Domestic revenue was 1.245 billion yuan, up 13.01% year-on-year, while overseas revenue reached 80.96 million yuan, a significant increase of 58.47% year-on-year [6] Future Earnings Forecast - The company is projected to achieve net profits of 193 million yuan, 252 million yuan, and 299 million yuan for the years 2025, 2026, and 2027, respectively [9]

Group 1 - The AI mobile concept sector increased by 3.02%, ranking 10th among concept sectors, with 24 stocks rising, including Shenghong Technology, Plutec, and Nanchip Technology, which rose by 16.30%, 8.41%, and 6.80% respectively [1] - The AI mobile concept sector saw a net inflow of 279 million yuan from main funds, with 15 stocks receiving net inflows, and 5 stocks exceeding 30 million yuan in net inflow, led by iFlytek with a net inflow of 112 million yuan [2][3] - The top stocks in terms of net inflow ratio included Sixuan New Materials, Bawei Storage, and Plutec, with net inflow ratios of 8.74%, 8.46%, and 7.86% respectively [3][4] Group 2 - The top stocks in the AI mobile concept sector based on today's performance included iFlytek, ZTE, Bawei Storage, and Plutec, with respective daily price changes of 1.29%, 1.87%, 4.26%, and 8.41% [3][4] - The trading volume and turnover rates for key stocks in the AI mobile concept sector were highlighted, with iFlytek having a turnover rate of 1.38% and a main fund flow of 112.42 million yuan [3][4] - The overall market performance of the AI mobile concept sector reflects a positive trend, indicating potential growth opportunities within the sector [1][2]

Core Viewpoint - The Chinese innovative pharmaceutical industry is transitioning from imitation to original innovation, with significant growth in outbound transactions and a promising future for internationalization [4] Group 1: Market Performance - As of May 29, 2025, the Sci-Tech Innovation Board 100 Index (000698) rose by 1.63%, with notable increases in constituent stocks such as Borui Pharmaceutical (688166) up 9.66% and Zhixiang Jintai (688443) up 6.57% [3] - The Sci-Tech 100 Index ETF (588030) increased by 1.60%, with a latest price of 0.95 yuan and a turnover rate of 1.16%, totaling 71.56 million yuan in transactions [3] - Over the past year, the average daily transaction volume of the Sci-Tech 100 Index ETF reached 424 million yuan, ranking first among comparable funds [3] Group 2: Fund Growth and Performance - The Sci-Tech 100 Index ETF saw a significant increase in scale, growing by 94.45 million yuan over the past two weeks, ranking second among comparable funds [4] - In the past week, the ETF's shares increased by 99 million, also ranking first among comparable funds [5] - The ETF has experienced a net inflow of 71.08 million yuan over the last five trading days, indicating strong investor interest [5] Group 3: Financial Metrics - As of May 28, 2025, the Sci-Tech 100 Index ETF's net value increased by 19.94% over the past year, with a maximum monthly return of 27.67% since inception [5] - The ETF's management fee is 0.15% and the custody fee is 0.05%, making it the lowest among comparable funds [5] - The tracking error for the ETF over the past six months is 0.016%, indicating high tracking precision compared to similar funds [5] Group 4: Industry Insights - From the beginning of 2025 to the present, the total outbound transaction amount for innovative drugs has reached 45.5 billion USD, with upfront payments totaling 2.2 billion USD, suggesting a record year ahead [4] - Most domestic innovative drugs currently in the U.S. are in clinical stages, with significant potential for future growth as they progress towards commercialization [4]

Core Viewpoint - Xi'an Plater Technology Co., Ltd. is preparing for its 2024 annual shareholders' meeting, focusing on maintaining shareholder rights and ensuring orderly proceedings while proposing significant changes to its governance structure, including the cancellation of the supervisory board and amendments to the company charter [1][22]. Group 1: Meeting Procedures and Governance Changes - The company has established guidelines for the 2024 annual shareholders' meeting to confirm the identity of attendees and ensure orderly conduct [2][3]. - The meeting will include discussions on various proposals, including the cancellation of the supervisory board and amendments to the company charter, which require shareholder approval [22][23]. - The company will implement a combination of on-site and online voting for the proposals presented during the meeting [11][12]. Group 2: Financial Performance Overview - For the reporting period, the company achieved a revenue of approximately 1,325.57 million yuan, representing a year-on-year increase of 15.02% [27]. - The net profit attributable to shareholders was approximately 104.44 million yuan, reflecting a decrease of 5.26% compared to the previous year [27]. - The company's total assets reached approximately 7,285.69 million yuan, an increase of 11.65% year-on-year, while total liabilities rose by 38.06% to approximately 2,467.75 million yuan [27]. Group 3: Operational Insights - The company reported a significant increase in operating costs, which rose by 36.31% to approximately 829.34 million yuan, impacting overall profitability [27]. - Research and development expenses amounted to approximately 211.30 million yuan, accounting for 15.94% of total revenue, indicating a commitment to innovation [27][32]. - The company continues to focus on the aerospace sector, which constituted 61.45% of total revenue, highlighting its strategic market positioning [29].